Comparison of Effect Sizes for TB vs Placebo groups between LuMOS and SRI-5
| Trial | Group (n) | LuMOS:Effect Size(95% CI) | SRI-5:Effect Size(95% CI) |
|---|---|---|---|
| ILLUMINATE-1 | TB-q4weeks (n=378) |
0.44
(0.30; 0.59) |
0.13
(− 0.02; + 0.27) |
| ILLUMINATE-1 | TB-q2weeks (n=381) |
0.42
(0.27; 0.56) |
0.05
(− 0.09; + 0.20) |
| ILLUMINATE-2 | TB-q4weeks (n=376) |
0.54
(0.39; 0.68) |
0.15
(+0.01; +0.30) |
| ILLUMINATE-2 | TB-q2weeks (n=372) |
0.69
(0.53; 0.83) |
0.23
(+0.08; +0.37) |